Innovation Pharmaceuticals Inc. Quarterly Return On Assets in % from Q1 2012 to Q3 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Innovation Pharmaceuticals Inc. quarterly/annual Return On Assets history and growth rate from Q1 2012 to Q3 2023.
  • Innovation Pharmaceuticals Inc. Return On Assets for the quarter ending September 30, 2023 was -34 %, a 20.2% increase year-over-year.
  • Innovation Pharmaceuticals Inc. annual Return On Assets for 2023 was -37.8 %, a 33.1% increase from 2022.
  • Innovation Pharmaceuticals Inc. annual Return On Assets for 2022 was -56.5 %, a 43.7% increase from 2021.
  • Innovation Pharmaceuticals Inc. annual Return On Assets for 2021 was -100 %, a 20.5% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2023 -34 +8.57 +20.2% Jul 1, 2023 Sep 30, 2023
Q2 2023 -37.8 -27 -252% Apr 1, 2023 Jun 30, 2023
Q1 2023 -26.6 +32.7 +55.1% Jan 1, 2023 Mar 31, 2023
Q4 2022 -32.1 +38.8 +54.7% Oct 1, 2022 Dec 31, 2022
Q3 2022 -42.5 +58.6 +58% Jul 1, 2022 Sep 30, 2022
Q2 2022 -10.7 +89.6 +89.3% Jun 10, 2022 Jun 30, 2022
Q1 2022 -59.4 +42.4 +41.6% Jan 1, 2022 Mar 31, 2022
Q4 2021 -70.9 +34.3 +32.6% Oct 1, 2021 Dec 31, 2021
Q3 2021 -101 -12.9 -14.7% Jul 1, 2021 Sep 30, 2021
Q2 2021 -100 +25.9 +20.5% Apr 1, 2021 Jun 30, 2021
Q1 2021 -102 +66.8 +39.6% Jan 1, 2021 Mar 31, 2021
Q4 2020 -105 +67 +38.9% Oct 1, 2020 Dec 31, 2020
Q3 2020 -88.2 +107 +54.8% Jul 1, 2020 Sep 30, 2020
Q2 2020 -126 +80.9 +39.1% Apr 1, 2020 Jun 30, 2020
Q1 2020 -169 +81.2 +32.5% Jan 1, 2020 Mar 31, 2020
Q4 2019 -172 +81.9 +32.2% Oct 1, 2019 Dec 31, 2019
Q3 2019 -195 +33 +14.5% Jul 1, 2019 Sep 30, 2019
Q2 2019 -207 +29.3 +12.4% Apr 1, 2019 Jun 30, 2019
Q1 2019 -250 -28.4 -12.8% Jan 1, 2019 Mar 31, 2019
Q4 2018 -254 -46.1 -22.2% Oct 1, 2018 Dec 31, 2018
Q3 2018 -228 -39.1 -20.7% Jul 1, 2018 Sep 30, 2018
Q2 2018 -236 -78.3 -49.5% Apr 1, 2018 Jun 30, 2018
Q1 2018 -221 -91.4 -70.4% Jan 1, 2018 Mar 31, 2018
Q4 2017 -208 -82.2 -65.4% Oct 1, 2017 Dec 31, 2017
Q3 2017 -189 -72.1 -61.7% Jul 1, 2017 Sep 30, 2017
Q2 2017 -158 -51.3 -48% Apr 1, 2017 Jun 30, 2017
Q1 2017 -130 -30.3 -30.4% Jan 1, 2017 Mar 31, 2017
Q4 2016 -126 -42 -50.1% Oct 1, 2016 Dec 31, 2016
Q3 2016 -117 -41 -54.1% Jul 1, 2016 Sep 30, 2016
Q2 2016 -107 -17.3 -19.3% Apr 1, 2016 Jun 30, 2016
Q1 2016 -99.6 -2.83 -2.92% Jan 1, 2016 Mar 31, 2016
Q4 2015 -83.8 +21.9 +20.7% Oct 1, 2015 Dec 31, 2015
Q3 2015 -75.8 +29.7 +28.1% Jul 1, 2015 Sep 30, 2015
Q2 2015 -89.5 -9.15 -11.4% Apr 1, 2015 Jun 30, 2015
Q1 2015 -96.8 -23.9 -32.8% Jan 1, 2015 Mar 31, 2015
Q4 2014 -106 -30 -39.7% Oct 1, 2014 Dec 31, 2014
Q3 2014 -105 -0.3 -0.29% Jul 1, 2014 Sep 30, 2014
Q2 2014 -80.3 +178 +68.9% Apr 1, 2014 Jun 30, 2014
Q1 2014 -72.9 +641 +89.8% Jan 1, 2014 Mar 31, 2014
Q4 2013 -75.7 +1.46K +95.1% Oct 1, 2013 Dec 31, 2013
Q3 2013 -105 +1.42K +93.1% Jul 1, 2013 Sep 30, 2013
Q2 2013 -259 +1.61K +86.1% Apr 1, 2013 Jun 30, 2013
Q1 2013 -714 +666 +48.3% Jan 1, 2013 Mar 31, 2013
Q4 2012 -1.54K Oct 1, 2012 Dec 31, 2012
Q3 2012 -1.53K Jul 1, 2012 Sep 30, 2012
Q2 2012 -1.87K Apr 1, 2012 Jun 30, 2012
Q1 2012 -1.38K Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.